Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity

M. Kolorz, L. Bartosova, J. Hosek, D. Dvorackova, A. Chylkova, V. Zboril, M. Batovsky, M. Bartos

. 2009 ; 30 Suppl 1 () : 137-142.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025381

Grantová podpora
NR9342 MZ0 CEP - Centrální evidence projektů

OBJECTIVES: Our study aims to find the relationship between metabolic enzyme thiopurine S-methyltransferase (TPMT) gene polymorphisms and clinical output of the therapy with azathioprine. We focused on patients who experienced leucopenia caused by high blood levels of active azathioprine metabolites. DESIGN: Our group consists of 87 patients who have been treated by azathioprine. 21 individuals experienced leucopenia during treatment with standard dose of azathioprine. We have used PCR-REA and "real-time" PCR methods for genotype detection G238C, G460G and A719G substitutions in TPMT gene. RESULTS: We have found statistical association between the presence of non-standard TPMT alleles and adverse event associated with azathioprine treatment - leucopenia (p=0.0033). CONCLUSION: Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy.

000      
00000naa a2200000 a 4500
001      
bmc12025381
003      
CZ-PrNML
005      
20140721131611.0
007      
ta
008      
120816s2009 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)20027160
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Kolorz, Michal. $7 _BN006015 $u Department of Human Pharmacology and Toxicology, University of Veterinary and Pharmaceutical Sciences Brno,, Czech Republic. michalkolorz@seznam.cz
245    10
$a Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity / $c M. Kolorz, L. Bartosova, J. Hosek, D. Dvorackova, A. Chylkova, V. Zboril, M. Batovsky, M. Bartos
520    9_
$a OBJECTIVES: Our study aims to find the relationship between metabolic enzyme thiopurine S-methyltransferase (TPMT) gene polymorphisms and clinical output of the therapy with azathioprine. We focused on patients who experienced leucopenia caused by high blood levels of active azathioprine metabolites. DESIGN: Our group consists of 87 patients who have been treated by azathioprine. 21 individuals experienced leucopenia during treatment with standard dose of azathioprine. We have used PCR-REA and "real-time" PCR methods for genotype detection G238C, G460G and A719G substitutions in TPMT gene. RESULTS: We have found statistical association between the presence of non-standard TPMT alleles and adverse event associated with azathioprine treatment - leucopenia (p=0.0033). CONCLUSION: Our results confirm that TPMT genotyping prior to the treatment with azathioprine could predict patients with genetic predisposition for serious leucopenia and seems to be a useful genetic marker for individualisation of the therapy.
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a azathioprin $x škodlivé účinky $x krev $7 D001379
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a leukopenie $x chemicky indukované $7 D007970
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methyltransferasy $x genetika $7 D008780
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a sekvenční analýza DNA $7 D017422
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bartošová, Ladislava $7 ola2006340376
700    1_
$a Hošek, Jan $7 xx0106185
700    1#
$a Dvořáčková, D. $7 _AN036503
700    1#
$a Chýlková, Alicja. $7 _AN052201
700    1_
$a Zbořil, Vladimír, $d 1955- $7 mzk2005278248
700    1_
$a Bátovský, Marián, $d 1951- $7 jo2007286430
700    1_
$a Bartoš, Milan, $d 1964- $7 xx0037128
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 137-142
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20027160 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20140721131918 $b ABA008
999    __
$a ok $b bmc $g 947423 $s 782727
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 30 Suppl 1 $d 137-142 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
GRA    __
$a NR9342 $p MZ0
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Možnosti archivace